Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-2180
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-2180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lbl500902281
Lbl500902519
Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
The text is discussing recommendations related to the interaction of a drug called "cimetane" with the analyte "aniatxine." The text provides PK fold change and 90% CI recommendations, cautionary language about concomitant use, dosing adjustment recommendations, and mentions of clinical significance and monitoring. The text does not provide information about the drugs' uses or indications.*
Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)
Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)
Chemical Structure (Venlafaxine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.